CN100367954C - Andrographolide soft capsule formulation and preparation method - Google Patents

Andrographolide soft capsule formulation and preparation method Download PDF

Info

Publication number
CN100367954C
CN100367954C CNB031419259A CN03141925A CN100367954C CN 100367954 C CN100367954 C CN 100367954C CN B031419259 A CNB031419259 A CN B031419259A CN 03141925 A CN03141925 A CN 03141925A CN 100367954 C CN100367954 C CN 100367954C
Authority
CN
China
Prior art keywords
andrographolide
soft capsule
gelatin
medicinal liquid
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031419259A
Other languages
Chinese (zh)
Other versions
CN1481792A (en
Inventor
张川
张卫东
苏娟
周耘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG XIER KANGTAI PHARMACEUTICAL CO., LTD.
Original Assignee
BOTAI MEDICINE SCIENCE AND TECHNOLOGY Co Ltd SHANGHAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOTAI MEDICINE SCIENCE AND TECHNOLOGY Co Ltd SHANGHAI filed Critical BOTAI MEDICINE SCIENCE AND TECHNOLOGY Co Ltd SHANGHAI
Priority to CNB031419259A priority Critical patent/CN100367954C/en
Publication of CN1481792A publication Critical patent/CN1481792A/en
Application granted granted Critical
Publication of CN100367954C publication Critical patent/CN100367954C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a green chiretta lactone soft capsule preparation and a preparation method thereof. In the present invention, capsule medicine liquid comprises green chiretta lactone in enough dosage as an effective component; the green chiretta lactone is matched with medicinal auxiliary materials in a proper proportion; the medicinal auxiliary materials comprise a diluting agent, a suspending agent, an antioxidant, a preservative, etc.; a capsule shell is mainly composed of gelatin, glycerin and water. The soft capsule prepared by the present invention has the advantages of stable quality, convenient taking, fast dissolution of effective components and timely effect.

Description

Andrographolide soft capsule formulation and preparation method thereof
Technical field
The invention belongs to medical technical field, be specifically related to a kind of pharmaceutical preparation of andrographolide,, the invention still further relates to the preparation method of said preparation simultaneously more specifically to a kind of andrographolide soft capsule.
Background technology
Andrographolide has the effect of heat-clearing and toxic substances removing, anti-inflammation, is used for upper respiratory tract infection, bacillary dysentery clinically.
The preparation of andrographolide has injection and tablet etc. clinically at present, and injection exists the shortcoming of patient's medication inconvenience when curative effect can be affirmed.Tablet is because the dissolubility of andrographolide is bad, and the effective ingredient stripping is slow, and onset is slower.Simultaneously, the andrographolide bitter in the mouth, patient's doctor is relatively poor from property.Andrographolide soft capsule can overcome the above-mentioned shortcoming of injection and tablet.
Summary of the invention
The object of the present invention is to provide a kind of andrographolide soft capsule and production method thereof, product is an oral administered dosage form, its steady quality, and easy to use, disintegrate is fast, and onset is timely.
The andrographolide soft capsule that the present invention proposes is made of medicinal liquid and softgel shell two parts.Wherein, medicinal liquid contains the andrographolide of certain effective dose as effective ingredient, and is equipped with pharmaceutic adjuvant, and pharmaceutic adjuvant comprises diluent, antioxidant, antiseptic, suspending agent etc.; Softgel shell mainly is made up of gelatin, water and glycerol, and the weight proportion of gelatin and glycerol is 10: 3.15~10: 3.35.
The structural formula of Main Ingredients and Appearance andrographolide of the present invention is:
Figure C0314192500031
Diluent of the present invention can be one or more in Polyethylene Glycol, propylene glycol, vegetable oil, the mineral oil; Antioxidant can be one or more in ethylenediaminetetraacetic acid, disodium EDTA, dibenzylatiooluene, glycine, inositol, ascorbic acid, sodium ascorbate, lecithin, malic acid, hydroquinone, citric acid, succinic acid, the sodium pyrosulfite; Suspending agent is one or more in Cera Flava, ethylhydroxyethylcellulose, chitin, chitose, methylcellulose, carboxymethyl cellulose, agar, hydroxypropyl emthylcellulose, the xanthan gum etc.; Antiseptic is one or more in sorbic acid, sorbic acid methyl ester, methyl parahydroxybenzoate, ethylparaben, propyl p-hydroxybenzoate, butyl p-hydroxybenzoate, benzyl p-hydroxybenzoate, Sodium Methyl Hydroxybenzoate, benzoic acid, the benzyl alcohol; Can also add coloring agent, opacifier in the softgel shell, specifically can be in white carbon black, iron oxide black, cologne earth, iron oxide red, the titanium dioxide one or more.
Among the present invention, the medicinal liquid of andrographolide soft capsule, reasonable component weight proportion is as follows:
Andrographolide 1
Diluent 1.4~20
Suspending agent 0.04~1
Antioxidant 0.008~0.1
Antiseptic 0.008~0.1
In the process of research andrographolide soft capsule, solved following problem:
1, softgel shell prescription (being applicable to the oil-soluble medicinal liquid)
Gelatin, glycerol proportioning are difficult to grasp in the prescription of softgel shell.The amount of glycerol is too many, and softgel shell is softer, than being easier to extrusion; The amount of glycerol very little, softgel shell is harder, crisp, influences the quality stability and the disintegration time of soft capsule.Gelatin, glycerol proportioning to softgel shell have been carried out detailed experimental study, have obtained a proportioning preferably at last.
An amount of gelatin is added in the rustless steel glue pot, add suitable quantity of water again, airtight, 70 degree insulation 3hr, add glycerol, the coloring agent of test consumption more respectively, stir vacuumize degassing 2hr, put into gelatin heat-preserving container 70 degree insulation standing over night, second day moulding ball, drying at room temperature keeps sample and investigates 3 months, examination softgel shell outward appearance and physical property, found that gelatin and glycerol proportioning be 10: 3.15~10: 3.35 o'clock the most suitable.The softgel shell prescription that is filtered out is applicable to common preservation environment.
2, medicinal liquid prescription
The softgel shell of soft capsule has determined that the used diluent of medicinal liquid can not be water, ethanol and the bigger organic solvent of some toxicity, and ideal is oil substances.But because andrographolide is insoluble in vegetable oil, so the medicinal liquid prescription has adopted the oil suspension system.Simultaneously by a large amount of experiments, selected for use toxicity less, can well andrographolide be suspended in the suspending agent in the vegetable oil.
An amount of suspending agent is melted in an amount of vegetable oil, again andrographolide is added wherein, add suitable antioxidant afterwards and in storage process, take place rotten to prevent the medicinal liquid in the soft capsule.Every of soft gelatin capsule contains the amount of principal agent andrographolide to be determined, is generally 0.01-0.10g.
3, preparation technology
The preparation technology of andrographolide soft capsule may further comprise the steps:
Gelatin adds suitable quantity of water under stirring, treat that gelatin dissolves fully after, add glycerol, amount of colorant, stir, be incubated set aside for use after the vacuumize degassing.
Suspending agent is added in the vegetable oil, and mixing mixes andrographolide again with vegetable oil, treat complete mixing after, add antioxidant, antiseptic again, stir, room temperature leaves standstill.
The medicinal liquid for preparing is poured in the medicinal liquid bucket, suppressed soft capsule with mould.
Compare with existing other dosage forms of andrographolide, the advantage of andrographolide soft capsule is a steady quality, carries, convenient drug administration, and the effective ingredient stripping is fast, and onset speed is fast, and the shortcoming of bitter in the mouth is overcome.
The specific embodiment
Embodiments of the invention are as follows:
Embodiment 1;
Component amount (g/ grain)
Andrographolide 0.025
Polyethylene Glycol 0.225
Gelatin 0.16
Glycerol 0.09
Hydroxyethyl-cellulose 0.007
Citric acid 0.008
Sorbic acid methyl ester 0.001
Cera Flava 0.01
Water 0.25
Embodiment 2:
Component amount (g/ grain)
Andrographolide 0.05
Oleum Arachidis hypogaeae semen 0.39
Gelatin 0.12
Glycerol 0.05
Ethyl cellulose 0.008
Ethylenediaminetetraacetic acid 0.001
Benzoic acid 0.002
Cera Flava 0.02
Water 0.25
Embodiment 3:
Component amount (g/ grain)
Andrographolide 0.01
Oleum Glycines 0.08
Gelatin 0.18
Glycerol 0.08
Chitose 0.006
Ascorbic acid 0.007
Propyl p-hydroxybenzoate 0.002
Cera Flava 0.006
Water 0.25
The preparation technology of above embodiment andrographolide soft capsule is:
Take by weighing gelatin and add 100L gelatin retort, under stirring, add suitable quantity of water, airtight, treat that gelatin dissolves fully after, add glycerol, amount of colorant again, stir, vacuumize degassing 2 hours is put into the gelatin heat-preserving container, the insulation standing over night is stand-by.
Suspending agent is added in the diluent, and mixing takes by weighing andrographolide, pulverizes, and sieves, and with andrographolide and mixing diluents, treats to add antioxidant, antiseptic behind the complete mixing, stirs, and room temperature leaves standstill.
The gelatin heat-preserving container is suspended from certain altitude, the medicinal liquid for preparing is poured in the drug bucket, change mould and begin to press soft capsule, adjust the soft capsule device to scope of design, dry 24 hours, reject the soft gelatin capsule of presentation quality difference, with the soft gelatin capsule washing, dry 24 hours again, get the andrographolide soft capsule semi-finished product, the qualified back packing of quality inspection, labeling, packing promptly get the andrographolide soft capsule finished product.These capsule finished product quality are all very stable, and result of use is good.

Claims (7)

1. an andrographolide soft capsule is made of medicinal liquid and softgel shell two parts, it is characterized in that andrographolide that medicinal liquid contains effective dose as effective ingredient, and is equipped with pharmaceutic adjuvant, and pharmaceutic adjuvant comprises diluent, antioxidant, suspending agent, antiseptic; The weight proportion of medicinal liquid is: andrographolide is 1, and diluent is 1.4~20, and suspending agent is 0.04~1, and antioxidant is 0.008~0.1, and antiseptic is 0.008~0.1; Softgel shell mainly is made up of gelatin, water and glycerol, and the weight proportion of gelatin and glycerol is 10: 3.15~10: 3.35.
2. andrographolide soft capsule according to claim 1 is characterized in that diluent is one or more in Polyethylene Glycol, propylene glycol, vegetable oil, the mineral oil.
3. andrographolide soft capsule according to claim 1 is characterized in that antioxidant is one or more in ethylenediaminetetraacetic acid, disodium EDTA, dibenzylatiooluene, glycine, inositol, ascorbic acid, sodium ascorbate, lecithin, malic acid, hydroquinone, citric acid, succinic acid, the sodium pyrosulfite.
4. andrographolide soft capsule according to claim 1 is characterized in that suspending agent is one or more in Cera Flava, ethylhydroxyethylcellulose, chitin, chitose, methylcellulose, carboxymethyl cellulose, agar, hydroxypropyl emthylcellulose, the xanthan gum etc.
5. andrographolide soft capsule according to claim 1 is characterized in that antiseptic is one or more in sorbic acid, sorbic acid methyl ester, methyl parahydroxybenzoate, ethylparaben, propyl p-hydroxybenzoate, butyl p-hydroxybenzoate, benzyl p-hydroxybenzoate, Sodium Methyl Hydroxybenzoate, benzoic acid, the benzyl alcohol.
6. andrographolide soft capsule according to claim 1 is characterized in that also being added with coloring agent, opacifier in the softgel shell, is specially in white carbon black, iron oxide black, cologne earth, iron oxide red, the titanium dioxide one or more.
7. preparation method as the described andrographolide soft capsule of claim 1-6 is characterized in that may further comprise the steps:
Gelatin adds suitable quantity of water under stirring, treat that gelatin dissolves fully after, add glycerol, coloring agent, stir, be incubated set aside for use after the vacuumize degassing;
Suspending agent is added in the diluent, and mixing adds andrographolide again, treat complete mixing after, add antioxidant, antiseptic, stir, the quiet reason of room temperature is stand-by;
The medicinal liquid for preparing is poured in the medicinal liquid bucket, suppressed soft capsule with mould.
CNB031419259A 2003-07-29 2003-07-29 Andrographolide soft capsule formulation and preparation method Expired - Fee Related CN100367954C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031419259A CN100367954C (en) 2003-07-29 2003-07-29 Andrographolide soft capsule formulation and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031419259A CN100367954C (en) 2003-07-29 2003-07-29 Andrographolide soft capsule formulation and preparation method

Publications (2)

Publication Number Publication Date
CN1481792A CN1481792A (en) 2004-03-17
CN100367954C true CN100367954C (en) 2008-02-13

Family

ID=34155532

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031419259A Expired - Fee Related CN100367954C (en) 2003-07-29 2003-07-29 Andrographolide soft capsule formulation and preparation method

Country Status (1)

Country Link
CN (1) CN100367954C (en)

Also Published As

Publication number Publication date
CN1481792A (en) 2004-03-17

Similar Documents

Publication Publication Date Title
US20160136224A1 (en) Method for preparing a camellia nitidissima chi lipid-lowering and hypoglycemic agent
CN104546807A (en) Olanzapine oral fast dissolving film preparation
CN100367954C (en) Andrographolide soft capsule formulation and preparation method
JP2021523195A (en) HC-1119 formulation and its manufacturing method and use
CN100544707C (en) panacea grass soft capsule and production method thereof
CN102670956B (en) Application of Chinese medicinal composition to preparation of anti-myocardial cell apoptosis and/or anti-myocardial cell apoptosis related disease drug
CN100348215C (en) Kaihoujian drip pill for treating throat disease and its preparation method
CN108685876A (en) It is a kind of to take orally membranaceous pharmaceutical composition containing Risperidone
CN1543942A (en) Haw leaf general flavone soft capsule and preparation thereof
CN104490802A (en) Salidroside enteric-coated tablets and preparation method thereof
CN1481883A (en) Fleabane soft capsule formulation and its preparation method
CN1069520C (en) Breviscapine soft capsule and its production method
CN100358506C (en) Compound musk drip pill and its preparation method
CN1449765A (en) Puerarin soft capsule pharmaceutics and preparation process thereof
CN111450076A (en) L emborexant soft capsule composition and preparation method thereof
CN100364506C (en) Drop pills preparation in use for treating bronchitis and preparation method
CN100363018C (en) Honeysuckle flower soft capsule and preparation method thereof
CN104434861B (en) Ambroxol hydrochloride osmotic pump controlled release tablet and preparation method thereof
CN1069519C (en) Bulleyaconitine A soft capsule and its production method
CN101513393A (en) Silymarin soft capsule and method for preparing same
CN1839849A (en) Cucurbitacin soft capsule and its preparation process
CN1259038C (en) Radix bupleuri soft capsule pharmaceutics and preparation process thereof
CN1315472C (en) Motherwort dropping pill and its preparing method
CN1064258C (en) Soft capsule of notoginseng extract and its preparing process
CN100358497C (en) Drop pills of canary-creeper and preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SHANDONG XIERKANGTAI PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: BOTAI MEDICINE SCIENCE AND TECHNOLOGY CO., LTD., SHANGHAI

Effective date: 20121025

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 200433 YANGPU, SHANGHAI TO: 272100 JINING, SHANDONG PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20121025

Address after: Xin Yan Zhen Private Industrial Park 272100 Shandong city of Yanzhou Province

Patentee after: SHANDONG XIER KANGTAI PHARMACEUTICAL CO., LTD.

Address before: 3021 room 335, No. 200433, National Road, Shanghai

Patentee before: Botai Medicine Science and Technology Co., Ltd., Shanghai

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080213

Termination date: 20150729

EXPY Termination of patent right or utility model